CRM Research Update — July 8, 2026
Updated Thesis
Salesforce, Inc. is a leading provider of cloud-based software applications primarily focused on customer relationship management (CRM). The company exhibits high business quality with a durable competitive moat supported by strong gross margins of 77.6%, solid operating margin of 21.9%, and a robust return on equity of 14.9%.
The investment grade as of this refresh is A — high business quality. High-tier business, cheap valuation with 45% upside to $245.80 fair value
Key Metrics at a Glance
- Revenue growth: +13.3% year over year
- Net margin: 18.7%
- Forward P/E: 19.6x
- Fair value upside: +45.0% to our estimate of $246
Current price: $169.52
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Salesforce, Inc. remains in our covered universe with a high-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full CRM research →](/stocks/CRM)